Editorials

Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-versus-host disease

Blood and Marrow Transplantation and Cellular Immunotherapy H. Lee Moffitt Cancer Center and Research Institute Tampa, FL
Blood and Marrow Transplantation and Cellular Immunotherapy H. Lee Moffitt Cancer Center and Research Institute Tampa, FL
Haematologica Early view May 12, 2022 https://doi.org/10.3324/haematol.2022.281168